Gene: MRPL40
Official Full Name: mitochondrial ribosomal protein L40provided by HGNC
Gene Summary: Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Deletions in this gene may contribute to the etiology of velo-cardio-facial syndrome and DiGeorge syndrome. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00046 | MRPL40 Knockout cell line (C4-2B) | Human | MRPL40 | 1:2-1:3 | Negative | Online Inquiry |
MRPL40 Gene Knockout Cell Lines are specially engineered cellular models designed to study the role of the MRPL40 gene, which encodes a mitochondrial ribosomal protein involved in protein synthesis within mitochondria. These knockout cell lines are created through CRISPR-Cas9 technology, resulting in a precise disruption of the MRPL40 gene, allowing researchers to elucidate its specific functions and assess its impact on cellular physiology, mitochondrial biogenesis, and bioenergetics.
The primary mechanism of action involves the impairment of mitochondrial translation, leading to downstream effects on cellular energy metabolism. By utilizing these knockout cell lines, scientists can observe alterations in mitochondrial function, oxidative stress responses, and the overall metabolic phenotype of cells lacking MRPL40. This provides valuable insights into the gene’s role in diseases linked to mitochondrial dysfunction, such as neurodegenerative disorders, metabolic syndromes, and certain forms of cancer.
The scientific importance of MRPL40 Gene Knockout Cell Lines lies in their applications in both basic and translational research. These models facilitate investigations into mitochondrial pathophysiology, mechanisms of stress response, and the interplay between mitochondrial function and cellular health. They serve as essential tools for drug discovery and validation, particularly for therapies aimed at mitochondrial diseases.
When compared to traditional cell lines, MRPL40 knockout models ensure higher specificity and reliability in results, minimizing off-target effects. They offer a more accurate representation of the physiological conditions encountered in vivo, which can significantly enhance the translational potential of research findings.
Research institutions and clinical laboratories will find immense value in acquiring MRPL40 Gene Knockout Cell Lines, as they provide a unique opportunity to unlock critical biological questions tied to mitochondrial health. Our company specializes in producing high-quality and precisely engineered biological products, underscored by our commitment to advancing research in molecular biology and genetics. With our expertise, we strive to support researchers in the quest for breakthroughs in understanding complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.